# Xilio Therapeutics, Inc.: Form 8-K, filed Nov 7, 2025

- Company: [Xilio Therapeutics, Inc.](/companies/xlo.md) (CIK 1840233)
- Form: 8-K
- Filed: 2025-11-07
- Accepted by EDGAR: Nov 7, 2025, 09:05 ET
- Period: 2025-11-07
- Accession: 0001193125-25-271189
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1840233/000119312525271189/xlo-20251107.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840233/000119312525271189/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840233/000119312525271189/xlo-20251107.htm

Filed Nov 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-271189. Last ingested by Listed: Nov 12, 2026, 19:19 ET. No prices; not investment advice.